Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study
Magdalena Stępień, Pekka Keski‐Rahkonen, Agnèta Kiss, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 3, pp. 609-625
Open Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

Data Processing Thresholds for Abundance and Sparsity and Missed Biological Insights in an Untargeted Chemical Analysis of Blood Specimens for Exposomics
Dinesh Kumar Barupal, ‪Sadjad Fakouri Baygi‬, Robert O. Wright, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 15
Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethylnitrosamine (DEN) Model of Liver Carcinogenesis
Natalia I. Krupenko, Jaspreet Sharma, Halle M. Fogle, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3219-3219
Open Access | Times Cited: 15
Biomarkers for hepatocellular carcinoma based on body fluids and feces
Ming‐Cheng Guan, Wei Ouyang, Ming-Da Wang, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 5, pp. 351-365
Open Access | Times Cited: 14
Dysbiosis: The first hit for digestive system cancer
Si Mei, Zhe Deng, Yating Chen, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 9
Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
Catherine T. Yu, Zeinab Farhat, Alicia A. Livinski, et al.
Cancer Epidemiology Biomarkers & Prevention (2023) Vol. 32, Iss. 9, pp. 1130-1145
Open Access | Times Cited: 5
Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk
Naoto Kubota, Naoto Fujiwara, Yujin Hoshida
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3843-3843
Open Access | Times Cited: 13
Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients
Mélanie Bourgin, Lisa Derosa, Carolina Alves Costa Silva, et al.
Aging (2021) Vol. 13, Iss. 17, pp. 20860-20885
Open Access | Times Cited: 11
A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
Lin‐Lin Cao, Yi Han, Lin Pei, et al.
Metabolites (2022) Vol. 12, Iss. 7, pp. 610-610
Open Access | Times Cited: 7
Circulating Metabolic Markers Related to the Diagnosis of Hepatocellular Carcinoma
Da Xie, Guangcong Zhang, Yanan Ma, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 6
Serum metabolomic analyses reveal the potential metabolic biomarkers for prediction of amatoxin poisoning
Yarong Liu, Shumei Li, Feng Yang, et al.
Toxicon (2023) Vol. 230, pp. 107153-107153
Open Access | Times Cited: 3
Molecular and Metabolic Phenotyping of Hepatocellular Carcinoma for Biomarker Discovery: A Meta-Analysis
Nguyễn Hoàng Anh, Nguyen Phuoc Long, Young Jin Min, et al.
Metabolites (2023) Vol. 13, Iss. 11, pp. 1112-1112
Open Access | Times Cited: 3
Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer
Lin‐Lin Cao, Yi Han, Yuanxiao Wang, et al.
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 5
Quantitative Analysis of Methylated Adenosine Modifications Revealed Increased Levels of N6-Methyladenosine (m6A) and N6,2′-O-Dimethyladenosine (m6Am) in Serum From Colorectal Cancer and Gastric Cancer Patients
Yiqiu Hu, Zhihao Fang, Jiayi Mu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 6
Metabolic signatures of hepatolithiasis using ultra-high performance liquid chromatography-tandem mass spectrometry
Cong Wang, Jun Yang, Enliang Li, et al.
Metabolomics (2022) Vol. 18, Iss. 9
Closed Access | Times Cited: 4
The past, present and future of liver cancer control for Māori
Jason Gurney, Sydney Clough, Tara Cleverley, et al.
New Zealand medical journal (2022) Vol. 135, Iss. 1567, pp. 91-104
Open Access | Times Cited: 4
UPLC-Q-TOF-MS/MS-based urine metabolomics studies on the toxicity and detoxication of Tripterygium wilfordii Hook. f. after roasting
Shu Chen, Li Liu, Hong‐Xia Jiang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 234, pp. 115573-115573
Closed Access | Times Cited: 2
Identification of pre‐diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case‐control study within the ATBC cohort
Dinesh Kumar Barupal, Mark Ramos, Andrea A. Florio, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 3, pp. 454-464
Open Access | Times Cited: 2
Chemical components and protective effects of Atractylodes japonica Koidz. ex Kitam against acetic acid-induced gastric ulcer in rats
Bixian Zhen, Qian Cai, Feng Li
World Journal of Gastroenterology (2023) Vol. 29, Iss. 43, pp. 5848-5864
Open Access | Times Cited: 2
Metabolomics for oncology
Susan Costantini, Alfredo Budillon
Elsevier eBooks (2022), pp. 553-604
Closed Access | Times Cited: 3
Identification of Warning Transition Points from Hepatitis B to Hepatocellular Carcinoma Based on Mutation Accumulation for the Early Diagnosis and Potential Drug Treatment of HBV-HCC
Fei Xu, Qingkang Meng, Feng Wu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-29
Open Access | Times Cited: 3
Optimal transport for automatic alignment of untargeted metabolomic data
Marie Breeur, George Stepaniants, Pekka Keski‐Rahkonen, et al.
(2024)
Open Access
Optimal transport for automatic alignment of untargeted metabolomic data
Marie Breeur, George Stepaniants, Pekka Keski‐Rahkonen, et al.
eLife (2024) Vol. 12
Open Access
Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma
Minami Yamauchi, Masamitsu Maekawa, Toshihiro Sato, et al.
Metabolites (2024) Vol. 14, Iss. 9, pp. 513-513
Open Access
Differences in the serum metabolomic profile of progressive alcohol-related liver disease in comparison to non-progressive alcohol-related liver disease: a cross sectional metabolomics study
Eemeli Puhakka, Hany Ahmed, Retu Haikonen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study
Cheng‐Hong Jiang, P F Lin, Fa‐Chun Chen, et al.
Journal of Proteome Research (2021) Vol. 21, Iss. 3, pp. 822-832
Closed Access | Times Cited: 4

Scroll to top